Kura Oncology与Caspian联合宣布,KO-7246在糖尿病治疗领域展现出成为同类最佳Menin抑制剂的潜力。
Kura Oncology与Caspian联合宣布,KO-7246在糖尿病治疗领域展现出成为同类最佳Menin抑制剂的潜力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.